Completed NA INTERVENTIONAL 2-arm
NCT06399744
Role of Sclerotherapy in Treatment of Non-neoplastic Ovarian Cyst
Sponsor: Al-Azhar University
Conditions
Benign Ovarian Cyst
Interventions
sclerotherapy
Updated 3 times since 2024 Last updated: May 3, 2024 Started: Sep 1, 2022 Primary completion: Jan 30, 2024 Completion: Feb 28, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Benign Ovarian Cyst and is currently completed. Al-Azhar University leads this study, which shows 3 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2024 — Jul 2024 [monthly]
Completed NA
First recorded
Sep 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Al-Azhar University
Data source: Al-Azhar University
For direct contact, visit the study record on ClinicalTrials.gov .